About this Journal Submit a Manuscript Table of Contents
Mediators of Inflammation
Volume 2013 (2013), Article ID 465319, 11 pages
http://dx.doi.org/10.1155/2013/465319
Review Article

How Histopathology Can Contribute to an Understanding of Defense Mechanisms against Cryptococci

1Department of Surgical Pathology, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo 143-8541, Japan
2Department of Neurosurgery, Toho University Ohashi Medical Center, 2-17-6 Ohashi, Meguro, Tokyo 153-8515, Japan
3Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-Ku, Tokyo 162-8640, Japan
4Laboratory of Space and Environmental Medicine, Graduate School of Medicine, Teikyo University, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan
5Teikyo University Institute of Medical Mycology, Hachioji, Tokyo 192-0395, Japan
6Department of Dermatology, Peking University First Hospital, Beijing, China

Received 31 May 2013; Accepted 18 July 2013

Academic Editor: Donna-Marie McCafferty

Copyright © 2013 Yoichiro Okubo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Invasive fungal infections, particularly those considered opportunistic, have become a common and significant complication of procedures performed in advanced contemporary medicine. Among such infections, cryptococcosis, which is usually caused by infection with Cryptococcus neoformans and Cryptococcus gattii, is particularly problematic because this fungal infection occurs in immunocompromised and apparently immunocompetent individuals. It has been largely accepted that Cryptococcus species are recognized by cellular receptors and that Th1-type immune responses play an important role in defense mechanisms against the yeast. However, the interaction between the yeast and host tissue varies depending on the characteristics of the yeast and the immune status of the host. To gain a better understanding of the pathophysiology of cryptococcosis, we wish to emphasize the usefulness of histopathological examinations, because it allowed more detailed information of an extremely complex interaction between the causative yeasts and tissue response. In the present review, we describe the pathophysiology of cryptococcosis as largely revealed in our previous histopathological investigations of the experimental infection.

1. Introduction

The increasing use of invasive monitoring and aggressive therapeutic technologies in developed countries has resulted in improved survival of individuals with life-threatening diseases [13]. However, it has also resulted in an increased number of patients at risk of invasive fungal infections, including cryptococcosis. Cryptococcosis is a localized or systemic fungal infection mainly caused by Cryptococcus neoformans (C. neoformans) and Cryptococcus gattii (C. gattii). C. neoformans is widely distributed throughout the world [4], whereas C. gattii has been limited in tropical and subtropical regions [5]. However, there was an outbreak of C. gattii infection in a temperate region of British Columbia in 1999, which expanded towards US Pacific Northwest and Japan [510].

Recent molecular biological investigations have contributed significantly toward an elucidation of the pathogenesis of the yeast. It has been largely accepted that Cryptococcus species are recognized by cellular receptors and that Th1-type immune responses play an important role in defense mechanisms against the yeast [11]. However, this defense mechanism may vary among individuals, depending on the agents, tissues involved, and immune status of the host [12, 13]. Therefore, experimental animal models remain essential for an elucidation of the pathophysiology of cryptococcosis. In particular, histopathological examination of lesions at the site of infection and altered structures generally reveals an extremely complex interaction between the causative microbes and tissue response [14]. In the present review, we describe the pathophysiology of cryptococcosis as largely revealed in our previous histopathological investigations using an experimental animal model of cryptococcosis.

2. Elucidation of Virulence Factors of Cryptococcus neoformans

Primary foci of a cryptococcal infection tend to be established in the lungs before disseminating to the central nervous system [15]. To determine the pathogenesis of pulmonary cryptococcosis, we conducted histopathological investigations using mouse models that had been infected with either C. neoformans TIMM 0362, a relatively high-virulence and thus high-mortality strain, or TIMM 0372, a relatively low-virulence and thus low-mortality strain, via the intranasal route of infection [16].

Histopathological examination of the lungs of mice infected with C. neoformans TIMM 0362 showed yeast cell proliferation in the alveoli and a lesser macrophage response (Figure 1(a)). Time-dependent histopathological examination revealed decreased macrophage response but increased yeast-cell proliferation and alveolar space expansion with disease progression. Ultimately, fatal infection was established that involved not only the lungs but also the brain and several other organs. In contrast, the lungs of mice infected with C. neoformans TIMM 0372 showed numerous yeast-containing multinucleated giant cells (MGCs) due to the prominent macrophage response (Figure 1(b)). Time-dependent histopathological examination revealed a decrease in the number of yeast cells and in the macrophage response at the late phase of infection, but little or no alveolar expansion throughout the observation period. The most significant histopathological findings in the lungs of mice infected with C. neoformans TIMM 0362 were poor macrophage response against invasion of yeast cells, subsequent structural alteration of the lungs, and induction of cerebral cystic lesions by fatal disseminated infection. To elucidate the poor macrophage response following infection by C. neoformans TIMM 0362, we focused on the cell-mediated immune response against the yeast. The interaction of major histocompatibility complex (MHC) class II molecules on the surface of the antigen-presenting cells (APCs) and CD4-positive T lymphocytes plays a central role in regulating the cell-mediated immune response against infection with the Cryptococcus species [11, 17]. We therefore investigated the expression of MHC class II IAd molecule on the macrophage in the lungs of mice infected with C. neoformans TIMM 0362 and TIMM 0372 by immunohistochemical examination. As a result, the former showed no expression of MHC class II IAd molecule, and the later expressed this molecule (Figure 2). In addition, an ultrastructural examination of the macrophage in the lung of mice infected with C. neoformans TIMM 0362 showed a small number of phagocytized yeasts and well-preserved organelles, including rough endoplasmic reticulum and Golgi (Figure 3(a)). In contrast, that with C. neoformans TIMM 0372 showed a large number of phagocytized yeasts, lipid droplets, and vacuolization (Figure 3(b)). These findings suggested that poor macrophage response confirmed by histopathological examinations implies the impaired Th1 dominant cell-to-cell interaction triggered by the recognition of APCs. In fact, similar phenomenon is confirmed in the nude mice. Namely, pulmonary cryptococcosis in homozygous (nu/nu) nude mice could not induce macrophage response (Figure 4(a)), whereas that in heterozygous nude mice could induce macrophage response with MGC formation (Figure 4(b)). Furthermore, similar histopathological findings were also observed in the lung of patients with acquired immunodeficiency syndrome (AIDS) [12, 18]. It has been well known that development of AIDS following infection with the human immunodeficiency virus (HIV) is associated with impaired cell-mediated immune response due to a reduction in CD4-positive T lymphocytes [1921]. Histopathological examinations indicated that the absence of CD4-positive T lymphocytes the decreasing function of antigen-presenting activity in macrophages of patients with AIDS [12], and a large number of yeasts in the septal capillaries were observed (Figure 5).

fig1
Figure 1: (a) The lung of mice infected with C. neoformans TIMM 0362 showed yeast cell proliferation in the alveoli but showed a very limited response of macrophage (13 days after infection, hematoxylin and eosin (HE) double stain, and original magnification ×200). (b) The lung of mice infected with C. neoformans TIMM 0372 showed numerous multinucleated giant cells (MGCs) due to the prominent macrophage response (13 days after infection, HE double stain, and original magnification ×200).
fig2
Figure 2: (a) Macrophages in the lung of mice infected C. neoformans TIMM 0362 showed no expression of MHC class II IAd molecule (immunohistochemistry, original magnification ×400). (b) Macrophages in the lung of mice infected with C. neoformans TIMM 0372 expressed the molecule MHC class II IAd molecule (immunohistochemistry, original magnification ×400).
fig3
Figure 3: (a) An ultrastructural examination of the macrophage in mice infected with C. neoformans TIMM 0362 showed that a large number of phagocytized lipid droplets and a small number of the yeasts, as well as lesser developed organelles. (b) An ultrastructural examination of the macrophage in mice infected with C. neoformans TIMM 0372 showed a large number of developed organelles, including rough endoplasmic reticulum and Golgi.
fig4
Figure 4: (a) Numerous and irregular-sized yeasts were diffusely observed in the pulmonary sections of cryptococcosis in homozygous (nu/nu) nude mice, but no multinucleated giant cell (MGC) was observed (periodic acid Schiff reaction, original magnification ×200). (b) MGCs with a well-developed and dense eosinophilic cytoplasm containing the yeasts were observed in the pulmonary sections of cryptococcosis in heterozygous nude mice (periodic acid Schiff reaction, original magnification ×200).
465319.fig.005
Figure 5: In patient with acquired immunodeficiency syndrome, a large number of yeast were observed in the pulmonary septal capillaries (periodic acid Schiff reaction, original magnification ×400).

The overall findings indicate that a Th1 dominant cell-to-cell interaction triggered by the macrophage recognition is one of the most important defense mechanisms against cryptococci. Our previous investigation revealed that inhaled C. neoformans TIMM 0362 can easily proliferate in alveoli due to the much lesser recognition by macrophages or other APCs via the MHC class II molecule, thereby causing greater structural alteration of the lungs and, ultimately, development of disseminated cryptococcosis. Consequently, poor cryptococcal yeast-cell recognition via macrophage or other APCs may be closely associated with the virulence of C. neoformans.

3. Differences in Pathophysiology between C. neoformans and C. gattii Infection

C. gattii, which was responsible for the cryptococcosis outbreak on Vancouver Island, Canada, causes life-threatening infections in immunocompetent individuals, whereas C. neoformans typically causes fatal diseases only in immunocompromised individuals [22]. To elucidate the differences between C. gattii and C. neoformans infection, we previously investigated and compared the biological characteristics of the pathogens and the pathophysiology of mice infected with C. neoformans H99, C. gattii 5815, and C. gattii R265 [23] which is causing an outbreak on Vancouver Island, Canada [6]. The mortality rate in mice infected with C. neoformans H99 and C. gattii R265 was significantly higher than that of mice infected with C. gattii 5815. However, there was no significant difference in mortality rate between mice infected with C. gattii R265 and C. neoformans H99. We examined certain biological characteristics. The results showed that only the growth rate under physiological conditions suggested a correlation with the mortality rate of infected mice.

We also conducted a detailed histopathological examination. We found a significant difference in histopathological findings of the lung between mice infected with C. gattii R265 and C. neoformans H99. In particular, the former infection showed a very limited macrophage response, but eccentric enlargement of the alveolar space was prominent due to extensive proliferation of the yeast (Figures 6(a) and 6(b)), while the latter infection showed an extensive macrophage response with giant cell formation (Figures 6(c) and 6(d)). These results may suggest that extensive proliferation of yeast in alveoli and subsequent alveolar expansion during C. gattii R265 infection and extensive macrophage response to intruding C. neoformans H99 result in a significant decrease of the pulmonary gas-exchange function of alveolar septa. This highlights the fact that the pathophysiology leading to death in C. gattii infection differs significantly from that of C. neoformans infection, whereas mice infected with both strains exhibited the same mortality rate.

fig6
Figure 6: (a) Pulmonary sections of mice infected with C. gattii R265 exhibited eccentric pulmonary enlargement (periodic acid Schiff (PAS) reaction, ×200). (b) Pulmonary sections of mice infected with C. gattii R265 showed multinucleated giant cells with a foamy cytoplasm, and a small number of nuclei that were loosely aggregated (PAS reaction, ×1000). (c) Pulmonary sections of mice infected with C. neoformans H99 showed multiple well-demarcated nodular lesions, but no alveolar expansion was observed (PAS reaction, ×200). (d) Pulmonary sections of mice infected with C. neoformans H99 showed multinucleated giant cells with a well-developed and dense eosinophilic cytoplasm and a large number of nuclei (PAS reaction, ×1000).

We now wish to describe the difference between the lungs of mice infected with C. gattii and C. neoformans. We found that sections of lungs from mice infected with both strains of C. gattii showed alveolar expansion, and the periphery of enlarged alveoli was usually encompassed by collapsed septa lying on top of each other. In contrast, sections of lungs from mice infected with C. neoformans H99 showed no alveolar expansion. This unique difference was also confirmed by our cross-point interval analysis, which is regarded as an indicator of structural alteration of the lung [24]. The results suggest that alveoli intruded by inhaled cryptococci were expanded due to extensive yeast proliferation, and that C. gattii can cause a greater structural alteration of the lung than C. neoformans.

Our study revealed that the poorest macrophage response was found in mice infected with C. gattii R265. It suggest that C. gattii R265 may have the poorest potential to induce a recognition cascade in the immune system which is consistent with a previous report [25]. We therefore conducted morphometric analyses of MGCs to quantitatively determine the strength of the macrophage response. We found that the findings of histopathological examinations may imply that C. gattii possesses some unknown mechanisms that allow it to avoid or escape recognition by macrophages or other antigen-presenting cells.

We now wish to provide more detailed discussion on the pathophysiology of cryptococcosis by comparing the previous investigation. Cheng et al. reported the histopathological differences between the mice infected with C. gattii R265 and C. neoformans H99 [26]. In their report, no significant difference was found for mortality rate between mice infected with C. gattii R265 and C. neoformans H99, as well as our present study. In addition, they suggested that C. neoformans H99 induces extensive neutrophil recruitment around the bronchovascular structures, but the ability was poor in C. gattii R265. Certainly, the same finding was also confirmed in our experimental murine model of cryptococcosis (Figures 7(a) and 7(b)). Since it has been reported that the migration of neutrophils into lung tissue is important in the early protection of mice against progressive cryptococcosis [27], the degree of neutrophil recruitment may be related to difference of pathophysiology between C. gattii and C. neoformans infections.

fig7
Figure 7: (a) Pulmonary sections of mice infected with C. gattii R265 exhibited poor neutrophil recruitment around the bronchovascular structures (arrowheads, hematoxylin and eosin (HE) double stain, and ×400). (b) Pulmonary sections of mice infected with C. neoformans H99 showed extensive neutrophil recruitment around the bronchovascular structures (arrowheads, HE double stain, and ×400).

On the other hand, Cheng et al. reported that no significant difference was found in number of macrophages between C. gattii R265 and C. neoformans H99 infected mice, whereas our study revealed that macrophage response of the mice infected with C. gattii R265 was poor, but that infected with C. neoformans H99 was extensive. The contradictory result may attribute to the difference of the experimental design and analysis methods. There were two important differences: one is routes of pulmonary infection (intranasal infection versus intratracheal infection), and another is term of infection (7 days versus 14 days). Since we were able to observe histopathological findings of the lesion just before death of the infected mice, macrophage response could be amplified in our study. In addition, Cheng et al. employed flow-cytometric analysis to count the number of macrophages that is superior to manual counting of the cell, but it cannot count the number of macrophages within MGC, accurately. Since macrophage fused together to form a MGC, the flow-cytometric analysis was unable to accurately assess the macrophage response.

Consequently, there is an extensively different pathophysiology leading to death between C. gattii and C. neoformans infections. Namely, both extensive proliferation of the yeast in alveoli during C. gattii R265 infection and macrophage response to intruding C. neoformans H99 would cause respiratory failure of the mice. Despite the same mortality rates between mice infected with C. gattii R265 and C. neoformans H99 was found, the pathophysiology leading to death between C. gattii and C. neoformans infection was different, which was only revealed by histopathological examination. We therefore wish to emphasize the usefulness of the yield of the histopathological examination for experimental animal model.

4. Exploration to Know Specific Virulence Factors of C. gattii

We found that C. gattii is characterized by its ability to induce high pulmonary structural alteration [23]. To gain an understanding of the cause of this unique feature, we investigated the characteristics of seven strains of C. gattii (TIMM 4097 and TIMM 4901 to 4906) [28, 29]. C. gattii TIMM 4097, TIMM 4901 to 4906 were isolated from Japanese zoo-bred koalas. Serotypes of the strain were confirmed using slide agglutination tests according to the manufacturer’s instructions (Cryptocheck Iatron RM 304-K kit; Mitsubishi Kagaku Iatron, Inc., Tokyo, Japan). All animal studies were performed in accordance with the guidelines and permission of the animal experiment care committee of the Teikyo University. On day 100 after infection, the cumulative mortality rates in mice infected with C. gattii TIMM 4097 was 10/10 (100.0%), whereas the rates in mice infected with C. gattii TIMM 4901 to 4906 were 0/10 (0.0%). According to Kaplan-Meier survival analysis with a log-rank significance test, the mortality rate in mice infected with C. gattii TIMM 4097 was significantly higher than that of mice infected with C. gattii TIMM 4901 to 4906.

To elucidate factors affecting virulence of the yeast, we examined biological characteristics of seven strains of C. gattii, including growth rate, capsule thickness, melanin production, and hydrolase (urease, proteinase, and phospholipase) activity. Despite the significant differences in mortality rate among mice infected with the different strains, no significant differences were found among the strains regarding any of the characteristics examined, except for growth rate. The results showed that only the growth rate suggested a correlation with the mortality rate of infected mice.

Since previous investigations have reported that the molecular type of a C. gattii strain plays a strong role in its virulence [22], we investigated the molecular type of seven strains of C. gattii using multilocus sequence typing (MLST) analysis in accordance with the consensus C. gattii typing scheme established by the Cryptococcal Working Group I of the International Society for Human and Animal Mycology (ISHAM) [30], which includes the following seven unlinked genetic loci: CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and IGS1. Although the mortality rate of mice infected with C. gattii TIMM 4907 was significantly higher than that of mice infected with C. gattii TIMM 4901 to 4906, MLST analysis revealed that the molecular type of all seven strains was VG I (Table 1), indicating that the virulence of these C. gattii strains may not be regulated by their molecular type.

tab1
Table 1: The molecular type of seven strains of Cryptococcus gattii was investigated using multilocus sequence typing (MLST) analysis. Although the mortality rate of mice infected with C. gattii TIMM 4907 was significantly higher than that of mice infected with C. gattii TIMM 4901 to 4906, MLST analysis revealed that the molecular type of all seven strains was VG I.

Whereas there were no differences in biological characteristics among the seven C. gattii strains of VG I isolated from Japanese zoo-bred koalas, the mortality rate of mice infected with C. gattii TIMM 4097 was significantly higher than that of mice infected with other six C. gattii strains. Therefore, we conducted detailed histopathological examination to gain an insight into the pathophysiology underlying the virulence. As the C. gattii TIMM 4901 to 4906 strains were found to have the same phenotypic expression, molecular type, and mortality rate in infected mice, C. gattii TIMM 4903 was randomly selected as a representative type for further examination and comparison with C. gattii TIMM 4097. Time-dependent histopathological examination revealed that pulmonary sections obtained from mice infected with C. gattii TIMM 4097 showed eccentric enlargement of alveoli containing prominent proliferation of yeast cells with disease progression (Figures 8(a) and 8(b)). In contrast, pulmonary sections of mice infected with C. gattii TIMM 4903 showed little or no alveolar expansion and contained a smaller number of yeast cells than sections of mice infected with C. gattii TIMM 4097 (Figures 8(c) and 8(d)), and quite interestingly, several yeast cells in the bronchi.

fig8
Figure 8: (a, b) On days 15 and 30 after infection, pulmonary sections of mice infected with C. gattii TIMM 4097 showed eccentric enlargement of alveoli containing prominent proliferation of yeast cells with disease progression (periodic acid Schiff (PAS) reaction, ×100, resp.). (c, d) On days 15 and 30 after infection, pulmonary sections of mice infected with C. gattii TIMM 4903 showed lesser degree of yeast cell proliferation and alveolar expansion than these with C. gattii TIMM 4097 (PAS reaction, ×100, resp.).

To gain a detailed understanding of the structural alteration of the lungs, the cross-point interval was measured. Analyses of the mean value and variance of the cross-point interval revealed significant differences between the mean value and variance of mice infected with C. gattii TIMM 4097 and 4903 on days 15 and 30 after infection (Figure 9). These results suggest that although alveoli invaded by inhaled cryptococci of any strain expand due to extensive yeast proliferation, inhalation of C. gattii TIMM 4097 may cause greater structural alteration of the lungs than C. gattii TIMM 4903 at a late phase of infection, which may be due to the greater ability of C. gattii TIMM 4097 to reside in the alveolar lumen compared to C. gattii TIMM 4903.

465319.fig.009
Figure 9: The (SD) values of the cross-point interval of the lungs of the mice infected with C. gattii TIMM 4097 on days 5, 10, 15, and 30 after infection were , , , and μm, respectively. In contrast, that of mice infected with C. gattii TIMM 4097 were , , , and μm, respectively. Analyses of the mean value and variance of the cross-point interval revealed significant differences between the mean value and variance of mice infected with C. gattii TIMM 4097 and 4903 on days 15 and 30 after infection.

The results of the histopathological examination and morphometric analysis of the lungs of infected mice indicated that infection with C. gattii TIMM 4097 (a high-virulence strain) tend to induce greater alteration of lung structure than infection with C. gattii TIMM 4903 (a low-virulence strain). To investigate the hypothesis that C. gattii TIMM 4097 tends to reside in the alveoli, the extent to which the yeast cells filled the bronchi was determined by semiquantitative assessment. All bronchi of the pulmonary PAS-stained sections were observed, and the bronchi were classified as “empty,” “partially full,” or “completely full” based on the degree to which the bronchi were filled with yeast cells. Results revealed that the ratio of “completely full” bronchi in mice infected with C. gattii TIMM 4903 was significantly higher than that of mice infected with C. gattii TIMM 4097 throughout the observation period (Figure 10). This assessment of the bronchi supported our hypothesis that C. gattii TIMM 4097 can rigidly reside in the alveoli. To test this hypothesis, the number of viable cells in the lungs and trachea of mice infected with each strain was also counted. Statistical analysis revealed that the mean log10 CFU count in the lungs of mice infected with C. gattii TIMM 4097 was significantly higher than that of mice infected with C. gattii TIMM 4903 in each evaluation period except for day 5 after infection (Figure 11). Nevertheless, and quite interestingly, the mean log10 CFU counts in the tracheae of mice infected with C. gattii TIMM 4903 on days 5, 10, and 15 after infection were significantly higher than those of mice infected with C. gattii 4097 (Figure 11). These results support the hypothesis that C. gattii TIMM 4097 tends to reside in the alveoli, whereas C. gattii TIMM 4903 tends to be washed out from the alveoli and move into the central side of the respiratory system.

465319.fig.0010
Figure 10: The percentage of bronchi that was “completely full” in mice infected with C. gattii TIMM 4097 on days 10, 15, and 30 after infection was 2.4, 4.9, and 7.1%, respectively, while that of mice infected with C. gattii 4903 was 5.0, 10.1, and 27.4%, respectively. Results revealed that the ratio of “completely full” bronchi in mice infected with C. gattii TIMM 4903 was significantly higher than that of mice infected with C. gattii TIMM 4097 throughout the observation period.
fig11
Figure 11: The log10 CFU/mL counts in the lungs of mice infected with C. gattii TIMM 4097 on days 5, 10, 15, and 30 after infection were , , , and , respectively, similar to those of mice infected with C. gattii TIMM 4903, which were , , , and , respectively. In contrast, the log10 CFU/mL counts in the tracheae of mice ys 5, 10, 15, and 30 after infection were , , , and , respectively, similar to those of mice infected with C. gattii TIMM 4903, which were , , , and , respectively. Statistical analysis revealed that the mean log10 CFU count in the lungs of mice infected with C. gattii TIMM 4097 was significantly higher than that of mice infected with C. gattii TIMM 4903 in each evaluation period except for day 5 after infection. Nevertheless, the mean log10 CFU counts in the tracheae of mice infected with C. gattii TIMM 4903 on days 5, 10, and 15 after infection were significantly higher than those of mice infected with C. gattii 4097.

A microarray assay with gene ontology analysis was also performed with reference to the previous investigation [31]. Gene expression in the lungs of mice infected with C. gattii TIMM 4097 and 4903 was measured and compared using microarray analysis (Affymetrix GeneChip microarrays). All the microarray data are deposited in GEO (accession number GSE48595). The microarray analysis detected the expression of 45,101 genes (Figure 12) and the probability of the value of each data point was indicated as a “flag,” such as “present” ( to <0.04), “marginal” ( to <0.06), or “absent” ( to <0.5). Gene expression that contained the “absent” flag (expression of 39,181 genes) was excluded, and the expression of 5,920 genes was extracted (Table 2). As referenced in previous investigations, a second selection was then performed using a cut-off value indicating at least a ±1.5-fold change (log 2 ratio). The results revealed that although 219 genes were upregulated in the lungs of mice infected with C. gattii TIMM 4097, only 175 genes were upregulated in the lungs of mice infected with C. gattii TIMM 4903. Thus, 35 genes were upregulated in the lungs of mice infected with either C. gattii TIMM 4097 or 4903, while 184 genes were upregulated only in the lungs of mice infected with C. gattii TIMM 4097 (Figure 13). To examine the hypothesis that upregulation of genes in mice infected with C. gattii TIMM 4097 is related to the high virulence of the strain, Gene Ontology (GO) analysis of the stored genes was conducted using the Biological Networks Gene Ontology tool (BINGO, http://www.psb.ugent.be/cbd/papers/BiNGO/) to identify statistically overrepresented GO categories among the biological data. For the 184 genes upregulated only in the lungs of mice infected with C. gattii TIMM 4097, 163 terms related to molecular functioning were detected, and GO terms related to binding accounted for about 75% of all terms (Figure 14).

tab2
Table 2: The probability of the value of each data point was indicated as a “flag,” such as “present” ( to < 0.04), “marginal” ( to < 0.06), or “absent” ( to < 0.5). Gene expression that contained the “absent” flag (expression of 39,181 genes) was excluded, and the expression of 5,920 genes was extracted.
465319.fig.0012
Figure 12: Gene expression in the lungs of mice infected with C. gattii TIMM 4097 and 4903 was measured and compared using microarray analysis. The microarray analysis detected the expression of 45,101 genes.
465319.fig.0013
Figure 13: Whereas 219 genes were upregulated in the lungs of mice infected with C. gattii TIMM 4097 (a high-virulence strain), only 175 genes were upregulated in the lungs of mice infected with C. gattii TIMM 4903 (a low-virulence strain). Thus, 35 genes were upregulated in the lungs of mice infected with either C. gattii TIMM 4097 or 4903, while 184 genes were upregulated only in the lungs of mice infected with C. gattii TIMM 4097.
465319.fig.0014
Figure 14: Analysis of the molecular function of stored genes was conducted using the Biological Networks Gene Ontology tool (BINGO, http://www.psb.ugent.be/cbd/papers/BiNGO/) to identify statistically overrepresented GO categories among the biological data. For the 184 genes upregulated only in the lungs of mice infected with C. gattii TIMM 4097, 163 terms related to molecular functioning were detected, and GO terms related to binding accounted for about 75% of all terms.

Our previous investigations suggested that C. gattii TIMM 4097 rigidly resides in the alveolar space and that this may cause alveolar expansion, whereas C. gattii TIMM 4903 is likely to be washed out from the alveoli and move into the central side of the respiratory system, as indicated by observation of little change in lung structure of mice infected with this strain. These differences may have arisen from the different capacity of the two strains to adhere onto the alveolar epithelium and is partly confirmed by our previous study.

5. Conclusion

The defense mechanism against cryptococci may vary among individuals, depending on the agents, tissues involved, and immune status of the host. Given these considerations, we wish to emphasize the usefulness of histopathological examinations, because it allowed more detailed information of an extremely complex interaction between the causative microbes and tissue response.

Authors’ Contributions

All authors contributed towards the conceptualization, writing, reading, and approval of the final version of the paper. In particular, Yoichiro Okubo and Naobumi Tochigi conceptualized this study, integrated the data, wrote the paper, and contributed equally to this work.

Conflict of Interests

Dr. Shibuya reports receiving research grants from Pfizer Inc., Janssen Pharmaceutical K. K., Dainippon Sumitomo Pharma Co., Astellas Pharma Inc., Taiho Pharmaceutical Co., and POLA-Pharma Inc. Other authors declare that they have no competing interests.

Acknowledgment

This work was supported by the Health Science Research Grants for Research on Emerging and Reemerging Infectious Diseases (H25-shinko-ippan-006 and H23-Shinkou-Ippan-018) from the Ministry of Health, Labor, and Welfare of Japan, a grant from the Strategic Basis on Research Grounds for Nongovernmental Schools at Heisei 20th, the Strategic Research Foundation Grant-Aided Project for Private schools at Heisei 23rd, KAKENHI to Yoichiro Okubo (no. 24790364) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Toho University project grant nos. 23-19, 21, and 28 and nos. 24-11, 16, 27, and 28, Yokohama Foundation for Advancement of Medical Science grant to Y. Okubo and M. Shinozaki, and Dr. Yanase’s grant of Toho University Medical School to Y. Okubo.

References

  1. K. Shimodaira, Y. Okubo, H. Nakayama et al., “Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University,” Mycoses, vol. 55, no. 5, pp. 435–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Okubo, T. Ishiwatari, H. Izumi et al., “Pathophysiological implication of reversed CT halo sign in invasive pulmonary mucormycosis: a rare case report,” Diagnostic Pathology, vol. 8, article 82, 2013. View at Publisher · View at Google Scholar
  3. Y. Okubo, M. Shinozaki, M. Wakayama et al., “Applied gene histopathology: identification of Fusarium species in FFPE tissue sections by in situ hybridization,” Methods in Molecular Biology, vol. 968, pp. 141–147, 2013. View at Publisher · View at Google Scholar
  4. J. F. Murray and J. Mils, “Pulmonary infectious complications of human immunodeficiency virus infection. Part II,” American Review of Respiratory Disease, vol. 141, no. 6, pp. 1582–1598, 1990. View at Google Scholar · View at Scopus
  5. A. Dixit, S. F. Carroll, and S. T. Qureshi, “Cryptococcus gattii: an emerging cause of fungal disease in North America,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2009, Article ID 840452, 13 pages, 2009. View at Publisher · View at Google Scholar
  6. L. MacDougall, S. E. Kidd, E. Galanis et al., “Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 42–50, 2007. View at Google Scholar · View at Scopus
  7. A. Upton, J. A. Fraser, S. E. Kidd et al., “First contemporary case of human infection with Cryptococcus gattii in puget sound: evidence for spread of the Vancouver Island outbreak,” Journal of Clinical Microbiology, vol. 45, no. 9, pp. 3086–3088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. D. Gillece, J. M. Schupp, S. A. Balajee et al., “Whole genome sequence analysis of Cryptococcus gattii from the pacific northwest reveals unexpected diversity,” PLoS ONE, vol. 6, no. 12, Article ID e28550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. J. Byrnes III, W. Li, Y. Lewit et al., “Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Okamoto, S. Hatakeyama, S. Itoyama et al., “Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007,” Emerging Infectious Diseases, vol. 16, no. 7, pp. 1155–1157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Voelz and R. C. May, “Cryptococcal interactions with the host immune system,” Eukaryotic Cell, vol. 9, no. 6, pp. 835–846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Shibuya, W. E. Coulson, J. S. Wollman et al., “Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome,” International Journal of Infectious Diseases, vol. 5, no. 2, pp. 78–85, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Shibuya, W. F. Coulson, and S. Naoe, “Histopathology of deep-seated fungal infections and detailed examination of granulomatous response against cryptococci in patients with acquired immunodeficiency syndrome,” Japanese Journal of Medical Mycology, vol. 43, no. 3, pp. 143–151, 2002. View at Google Scholar · View at Scopus
  14. D. Sasai, Y. Okubo, T. Ishiwatari et al., “Histopathological evaluation of the efficacy of antifungals for experimental Trichosporon bloodstream infection,” Japanese Journal of Infectious Diseases, vol. 66, no. 2, pp. 133–139, 2013. View at Google Scholar
  15. G. B. Huffnagle and L. K. McNeil, “Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment,” Journal of NeuroVirology, vol. 5, no. 1, pp. 76–81, 1999. View at Google Scholar · View at Scopus
  16. K. Shibuya, S. Naoe, K. Uchida, and H. Yamaguchi, “Histopathological study of murine pulmonary cryptococcosis,” Japanese Journal of Medical Mycology, vol. 29, no. 3, pp. 182–190, 1988 (Japanese). View at Google Scholar · View at Scopus
  17. E. E. McClelland, D. L. Granger, and W. K. Potts, “Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice,” Infection and Immunity, vol. 71, no. 8, pp. 4815–4817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Shibuya, A. Hirata, J. Omuta et al., “Granuloma and cryptococcosis,” Journal of Infection and Chemotherapy, vol. 11, no. 3, pp. 115–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Ruegg and E. G. Engleman, “Impaired immunity in AIDS: the mechanisms responsible and their potential reversal by antiviral therapy,” Annals of the New York Academy of Sciences, vol. 616, pp. 307–317, 1990. View at Google Scholar · View at Scopus
  20. Y. Okubo, M. Shinozaki, S. Yoshizawa et al., “Diagnosis of systemic toxoplasmosis with HIV infection using DNA extracted from paraffin-embedded tissue for polymerase chain reaction: a case report,” Journal of Medical Case Reports, vol. 4, article 265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Khoury, R. Rajasuriar, P. U. Cameron, and S. R. Lewin, “The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player,” Clinical Immunology, vol. 141, no. 3, pp. 253–267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Kidd, F. Hagen, R. L. Tscharke et al., “A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada),” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17258–17263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Okubo, M. Wakayama, H. Ohno et al., “Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans,” Japanese Journal of Infectious Diseases, vol. 66, no. 3, pp. 216–221, 2013. View at Google Scholar
  24. L. Knudsen, E. R. Weibel, H. J. G. Gundersen, F. V. Weinstein, and M. Ochs, “Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach,” Journal of Applied Physiology, vol. 108, no. 2, pp. 412–421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Ngamskulrungroj, Y. Chang, E. Sionov, and K. J. Kwon-Chung, “The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model,” mBio, vol. 3, no. 3, Article ID e00103-12, 2012. View at Publisher · View at Google Scholar
  26. P.-Y. Cheng, A. Sham, and J. W. Kronstad, “Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans,” Infection and Immunity, vol. 77, no. 10, pp. 4284–4294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Guillot, S. F. Carroll, R. Homer, and S. T. Qureshi, “Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection,” Infection and Immunity, vol. 76, no. 10, pp. 4745–4756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Sugamata, K. Makimura, K. Uchida, K. Shibuya, and T. Kakiuchi, “Histopathological features of two strains of Cryptococcus neoformans var. gattii with different virulence,” Journal of the Medical Society of Toho University, vol. 53, no. 2, pp. 105–117, 2006 (Japanese). View at Google Scholar · View at Scopus
  29. K. Makimura, M. Karasawa, H. Hosoi et al., “A Queensland koala kept in a Japanese zoological park was carrier of an imported fungal pathogen, Filobasidiella neoformans var. bacillispora (Cryptococcus neoformans var. gattii),” Japanese Journal of Infectious Diseases, vol. 55, no. 1, pp. 31–32, 2002. View at Google Scholar · View at Scopus
  30. W. Meyer, D. M. Aanensen, T. Boekhout et al., “Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii,” Medical Mycology, vol. 47, no. 6, pp. 561–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Shimodaira, Y. Okubo, E. Ochiai et al., “Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs,” Respiratory Research, vol. 13, article 103, 2012. View at Publisher · View at Google Scholar